Repligen Corp (RGEN)

NASDAQ · Life Sciences Tools & Services

189.50
+7.80 (+4.29%)
Updated Oct 6, 9:27 AM ET
AI Rating
Buy
Overall Score
69
Trend
100
Momentum
46
Risk
52

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Sep 23, 2025 260 sessions Oct 5, 2026

AI Analysis

Repligen Corp is trading at $189.50, up 4.29% on the session. The 50 day average sits at $169.67 and the 200 day at $143.51, which puts the stock in a uptrend. RSI is at 53, which reads as neutral, and MACD is bearish crossover. Volume is above average.

The nearest support is around $161.14 with resistance near $188.73, so that band frames the current range. Average daily movement is roughly $7.62, or about 4.0% of the share price, which is what any stop placement has to allow for. The overall health score of 69 out of 100 combines a trend score of 100, momentum of 46 and a risk score of 52.

Technical indicators

RSI (14)
53.0
neutral
MACD
5.102
bearish crossover
SMA 20
178.70
SMA 50
169.67
SMA 200
143.51
uptrend
ATR (14)
7.62
avg daily range
Support
161.14
Resistance
188.73
Volume vs 20d
1.33x
above average
Volatility
43.0%
annualised
1 month
+5.07%
3 months
+28.45%

AI trade signals on RGEN

All signals
Date Setup Entry Target Stop R:R Status
Sep 28 Breakout ••.•• ••.•• ••.•• 3.14:1 Stopped Out

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.